Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors

Brain Research

Volumn 844, Issue 1-2, 1999, Pages 106-117

  Hanania, Taleen ^a   Johnson, Kenneth M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

ACh release; Dopamine; GABA release; Glutamate; NMDA; Parkinson's disease; Striatum

Indexed keywords

AMPA RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHENCYCLIDINE;

4 AMINOBUTYRIC ACID RELEASE; ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ACETYLCHOLINE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BENZOATES; CARBON RADIOISOTOPES; CORPUS STRIATUM; CYCLOLEUCINE; DOPAMINE AGONISTS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLYCINE; KAINIC ACID; MALE; N-METHYLASPARTATE; PROLINE; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; TRITIUM;

EID: 0032861469     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01869-7     Document Type: Article

References (50)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
2. Avenet P., Leonardon J., Bernard F., Graham D., Depoortere H., Scatton B. Antagonist properties of liprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes. Neurosci. Lett. 223:1997;133-136.
3. Bernard V., Somigyi P., Bolam J.P. Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J. Neurosci. 17:1997;812-833.
4. Cepeda C., Buchwald N.A., Levine M.S. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc. Natl. Acad. Sci. 90:1993;9576-9580.
5. Colwell C.S., Levine M.S. Metabotropic glutamate receptors modulate N-methyl-D-aspartate receptor function in neostriatal neurons. Neuroscience. 61:1994;497-507.
6. De Montigny P., Stobaugh J.F., Givens R.S., Carlson R.G., Srinivasachar K., Sternson L.A., Higuchi T. Naphthalene-2,3,dicarboxaldehyde/cyanide ion: a rationally designed fluorogenic reagent for primary amines. Anal. Chem. 59:1987;1096-1101.
7. Emson P.C., Augood S.J., Senaris R., Guevara Guzman R., Kishimoto J., Kadowaki K., Norris P.J., Kendrick K.M. Chemical signalling and striatal interneurons. Prog. Brain Res. 99:1993;155-165.
8. Ferkany J.W., Zaczek R., Coyle J.T. Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature. 298:1982;757-759.
9. 2 dopamine receptors in acutely dissociated neurons from rat corpus striatum. Proc. Natl. Acad. Sci. 85:1988;3618-3622.
10. Greenamyre J.T., O'Brien C.F. N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease. Arch. Neurol. 48:1991;977-981.
11. Hanania T., Johnson K.M. Regulation of neurotransmitter release by endogenous nitric oxide in striatal slices. Eur. J. Pharmacol. 359:1998;111-117.
12. Harsing L.G. Jr., Zigmond M.J. Influence of dopamine on GABA release in striatum evidence for D1-D2 interactions and non-synaptic influences. Neuroscience. 77:1997;419-429.
13. Hayashi Y., Sekiyama N., Nakanishi S., Jane D.E., Sunter D.C., Birse E.F., Udvarhelyi P.M., Watkins J.C. Analysis of agonist and antagonist activities of phenylglycine derivatives for different cloned metabotropic glutamate receptor subtypes. J. Neurosci. 14:1994;3370-3377.
14. Hollmann M., Boullter J., Maron C., Beasley L., Sullivan J., Pecht G., Heinemann S. Zinc potentiates agonist-induced currents at certain slice variants of the NMDA receptor. Neuron. 10:1993;943-954.
15. Johnson K.M., Jeng Y.-J. Pharmacological evidence for N-methyl-D-aspartate receptors on nigrostriatal dopaminergic nerve terminals. Can. J. Physiol. Pharmacol. 69:1991;1416-1421.
16. Johnson K.M., Snell L.D. Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding. Pharmacol. Biochem. Behav. 22:1985;731-735.
17. Kita H. GABAergic circuits of the striatum. Prog. Brain Res. 99:1993;51-72.
18. Kita H. Glutamatergic and GABAergic postsynaptic responses of striatal spiny neurons to intrastriatal and cortical stimulation recorded in slice preparations. Neuroscience. 70:1996;925-940.
19. Kolaj M., Cheng C.G., Brickey D.A., Radic M. Alpha subunit of calcium/calmodulin-dependent protein kinase enhances excitatory amino acid and synaptic responses of rat spinal dorsal horn neurons. J. Neurophysiol. 72:1994;2525-2531.
20. Krebs M.O., Desce J.M., Kemel M.L., Gauchy C., Godeheu G., Cheramy A., Glowinski J. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56:1991;81-85.
21. Landwehrmeyer G.B., Standaert D.C., Testa C.M., Penny J.B. Jr., Young A.B. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15:1995;5297-5307.
22. Laurie D.J., Seeburg P.H. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. 268:1994;335-345.
23. 1 dopamine receptor gene. Proc. Natl. Acad. Sci. 88:1991;4205-4209.
24. +2-dependent phosphatase. Nature. 369:1994;235-239.
25. Markram H., Segal M. Activation of protein kinase C suppresses responses to NMDA in rat CA1 hippocampal neurons. J. Physiol. 457:1992;491-501.
26. 2 dopamine agonists. Brain Res. 739:1996;19-25.
27. Nankai M., Fage D., Carter C. Striatal NMDA receptor subtypes: the pharmacology of N-methyl-D-aspartate-evoked dopamine, γ-aminobutyric acid, acetylcholine and spermidine release. Eur. J. Pharmacol. 286:1995;61-70.
28. Nankai M., Klarica M., Fage D., Carter C. Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds. Neurochem. Int. 29:1996;529-542.
29. Nisenbaum E.S., Grace A.A., Berger T.W. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs: II. In vitro analysis. Neuroscience. 48:1992;579-593.
30. B type Eur. J. Pharamcol. 144:1987;45-52.
31. Pisani A., Calabresi P., Centonze D., Bernadi G. Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurons. Br. J. Pharmacol. 120:1997;1007-1014.
32. 2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices. Brain Res. 757:1997;17-23.
33. Rowlands G.J., Roberts P.J. Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminals in vitro. Eur. J. Pharmacol. 62:1980;241-242.
34. Scatton Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity. J. Pharmacol. Exp. Ther. 220:1982;197-202.
35. Schoepp D.D., Johnson B.G., Salhoff C.R., Valli M.J., Desal M.A., Burnett J.P., Mayne N.G., Monn J.A. Selective inhibition of forskoline-stimulated cyclic AMP formation in rat hippocampus by a novel mGluR agonist, 2R,4R-4-aminopyrrolidine-2,4,dicarboxylate. Neuropharmacology. 34:1995;843-850.
36. Schwarcz R., Creese I., Coyle J.T., Snyder J.T.S.H. Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum. Nature. 271:1987;766-768.
37. Sigel E., Baur R., Malherbe P. Protein kinase C transiently activates heteromeric N-methyl-D-aspartate receptor channels independent of the phosphorylatable C-terminal splice domain and of consensus phosphorylation sites. J. Biol. Chem. 269:1994;8204-8208.
38. Smith A.D., Bolam J.P. The neuronal network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci. 13:1990;259-265.
39. Snell L.D., Iorio K.R., Tabakoff B., Hoffman P.L. Protein kinase C activation attenuates N-methyl-D-aspartate-induced increases in intracellular calcium in cerebellar granule cells. J. Neurochem. 62:1994;1783-1789.
40. 3H -(1-[1-(2-thienyl)cyclohexyl]-piperidine) binding in rat hippocampus Synapse. 3:1989;129-135.
41. Snell L.D., Johnson K.M. Antagonism of N-methyl-D-aspartate-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior. J. Pharmacol. Exp. Ther. 235:1985;50-57.
42. Snell L.D., Johnson K.M. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. J. Pharmacol. Exp. Ther. 238:1986;938-946.
43. Snell L.D., Mueller Z.L., Gannon R.L., Silverman P.B., Johnson K.M. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo. J. Pharmacol. Exp. Ther. 231:1984;261-269.
44. Standaert D.G., Testa C.M., Rudolf G.D., Hollingsworth Z.R. Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation. J. Pharmacol. Exp. Ther. 276:1996;342-352.
45. Surmeier D.J., Song W.J., Yam Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16:1996;6579-6591.
46. Tingley W.G., Roche K.W., Thompson A.K., Huganir R.L. Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature. 364:1993;70-73.
47. Urushihara H., Tohda M., Nomura Y. Selective potentiation of N-methyl-D-aspartate-induced current by protein kinase C in Xenopus oocytes injected with rat RNA. J. Biol. Chem. 267:1992;11697-11700.
48. Wang J., Lonart G., Johnson K.M. Glutamate receptor activation induces carrier mediated release of endogenous GABA from rat striatal slices. J. Neural Transm. 103:1996;1-43.
49. Wang Y.T., Salter M.W. Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature. 369:1994;233-235.
50. Watkins J., Collingridge G. Phenylglycine derivatives as antagonists of metabotropic glutamate receptors. Trends Pharmacol. Sci. 15:1994;333-352.